BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Waite AAC, Hamilton DO, Pizzi R, Ageno W, Welters ID. Hypercoagulopathy in Severe COVID-19: Implications for Acute Care. Thromb Haemost 2020;120:1654-67. [PMID: 33368088 DOI: 10.1055/s-0040-1721487] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Telek E, Ujfalusi Z, Kemenesi G, Zana B, Jakab F, Hild G, Lukács A, Hild G. A Possible Way to Relate the Effects of SARS-CoV-2-Induced Changes in Transferrin to Severe COVID-19-Associated Diseases. IJMS 2022;23:6189. [DOI: 10.3390/ijms23116189] [Reference Citation Analysis]
2 Engelen MM, Vandenbriele C, Spalart V, Martens CP, Vandenberk B, Sinonquel P, Lorent N, De Munter P, Willems R, Wauters J, Wilmer A, Dauwe D, Gunst J, Guler I, Janssens S, Martinod K, Pieters G, Peerlinck K, Verhamme P, Vanassche T. Thromboprophylaxis in COVID‐19: Weight and severity adjusted intensified dosing. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12683] [Reference Citation Analysis]
3 Abrignani MG, Murrone A, De Luca L, Roncon L, Di Lenarda A, Valente S, Caldarola P, Riccio C, Oliva F, Gulizia MM, Gabrielli D, Colivicchi F, On Behalf Of The Working Group On Anti-Covid-Vaccination Of The Associazione Nazionale Medici Cardiologi Ospedalieri Anmco. COVID-19, Vaccines, and Thrombotic Events: A Narrative Review. J Clin Med 2022;11:948. [PMID: 35207220 DOI: 10.3390/jcm11040948] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Lip GYH, Rigby A, Weber C. A Rollercoaster Plunge into 2022. Thromb Haemost 2022;122:1-4. [PMID: 35038759 DOI: 10.1055/s-0041-1741073] [Reference Citation Analysis]
5 Weber C, Rigby A, Lip GYH. Thrombosis and Haemostasis 2021 Editors' Choice Papers. Thromb Haemost 2022;122:163-70. [PMID: 35038760 DOI: 10.1055/s-0041-1741072] [Reference Citation Analysis]
6 Kakar V, North A, Bajwa G, Raposo N, Kumar PG. Long Runs and Higher Incidence of Bleeding Complications in COVID-19 Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: A Case Series from the United Arab Emirates. Indian J Crit Care Med 2021;25:1452-8. [PMID: 35027808 DOI: 10.5005/jp-journals-10071-24054] [Reference Citation Analysis]
7 Zdanyte M, Rath D, Gawaz M, Geisler T. Venous Thrombosis and SARS-CoV-2. Hamostaseologie 2021. [PMID: 34879422 DOI: 10.1055/a-1661-0283] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Hamilton DO, Main-Ian A, Tebbutt J, Thrasher M, Waite A, Welters I. Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19. Thromb J 2021;19:87. [PMID: 34781984 DOI: 10.1186/s12959-021-00337-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 De Vita A, De Matteis G, d'Aiello A, Ravenna SE, Liuzzo G, Lanza GA, Massetti M, Crea F, Gasbarrini A, Franceschi F, Covino M. Incidence and Predictors of Thrombotic Complications in 4742 Patients with COVID-19 or Other Acute Infectious Respiratory Diseases: A Propensity Score-Matched Study. J Clin Med 2021;10:4973. [PMID: 34768490 DOI: 10.3390/jcm10214973] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Ahuja N, Bhinder J, Nguyen J, Langan T Jr, O'Brien-Irr M, Montross B, Khan S, Sharma AM, Harris LM. Venous thromboembolism in patients with COVID-19 infection: risk factors, prevention, and management. Semin Vasc Surg 2021;34:101-16. [PMID: 34642030 DOI: 10.1053/j.semvascsurg.2021.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Aguilar-Piedras MF, Porres-Aguilar M, Mukherjee D, Cueto-Robledo G, Roldan-Valadez E, Tapia-Vargas PA. High Flow Nasal Cannula Oxygenation Successfully Used as Bridge Therapy for Systemic Thrombolysis in COVID-19 Associated Intermediate-high Risk Pulmonary Embolism. Curr Probl Cardiol 2021;:101000. [PMID: 34571100 DOI: 10.1016/j.cpcardiol.2021.101000] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Arcanjo A, Pinto KG, Logullo J, Leite PEC, Menezes CCB, Freire-de-Lima L, Diniz-Lima I, Decoté-Ricardo D, Rodrigues-da-Silva RN, Freire-de-Lima CG, Filardy AA, Lima-Junior JDC, Bertho AL, De Luca PM, Granjeiro JM, Barroso SPC, Conceição-Silva F, Savino W, Morrot A. Critically ill COVID-19 patients exhibit hyperactive cytokine responses associated with effector exhausted senescent T cells in acute infection. J Infect Dis 2021:jiab425. [PMID: 34427670 DOI: 10.1093/infdis/jiab425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Covino M, De Matteis G, Della Polla D, Burzo ML, Pascale MM, Santoro M, De Cristofaro R, Gasbarrini A, De Candia E, Franceschi F. Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients? Aging Clin Exp Res 2021;33:2335-43. [PMID: 34216379 DOI: 10.1007/s40520-021-01924-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Poor HD. Pulmonary Thrombosis and Thromboembolism in COVID-19. Chest 2021:S0012-3692(21)01126-0. [PMID: 34153340 DOI: 10.1016/j.chest.2021.06.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
15 Engelen MM, Vandenbriele C, Balthazar T, Claeys E, Gunst J, Guler I, Jacquemin M, Janssens S, Lorent N, Liesenborghs L, Peerlinck K, Pieters G, Rex S, Sinonquel P, Van der Linden L, Van Laer C, Vos R, Wauters J, Wilmer A, Verhamme P, Vanassche T. Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization. Semin Thromb Hemost 2021;47:362-71. [PMID: 33893631 DOI: 10.1055/s-0041-1727284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]